Glimepiride — Nutrient Associations & Health Patterns
Also known as: Glimepiride (Amaryl)
Drug Class: Sulfonylurea (Diabetes medication)
Second-generation sulfonylurea that stimulates insulin release from pancreatic beta cells. Used for type 2 diabetes to lower blood sugar levels. Often combined with metformin for enhanced glucose control. Only evidence-qualified catalog relationships are listed here. Other catalog entries remain unverified in this reference; absence from the list does not rule out other medication effects or interactions.
Medication and Nutrition Context
Only evidence-qualified catalog relationships are listed here. Other catalog entries remain unverified in this reference; absence from the list does not rule out other medication effects or interactions.
Common Side Effects of Glimepiride
- Hypoglycemia (low blood sugar)
- Weight gain
- Headache
- Nausea
- Dizziness
- Weakness
- Flu-like symptoms
- Hemolytic anemia (rare, especially with G6PD deficiency)
Key Drug Interactions — Glimepiride
Glimepiride has 15 documented drug-drug interactions in WePattern's Pattern Health Intelligence database. Key interactions include:
- Insulin
- Fluconazole
- Miconazole
- NSAIDs
- Warfarin
- Beta-blockers (may mask hypoglycemia symptoms)
Frequently Asked Questions
What nutrient associations are reported for Glimepiride?
Only evidence-qualified catalog relationships are listed here. Other catalog entries remain unverified in this reference; absence from the list does not rule out other medication effects or interactions.
Which nutrient relationships are mapped for Glimepiride?
Only evidence-qualified catalog relationships are listed here. Other catalog entries remain unverified in this reference; absence from the list does not rule out other medication effects or interactions.
What are the side effects of Glimepiride?
Common side effects associated with Glimepiride include: Hypoglycemia (low blood sugar); Weight gain; Headache; Nausea; Dizziness.